SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Dekker Christopher F

(Last) (First) (Middle)
C/O BRUNSWICK CORPORATION
26125 N. RIVERWOODS BLVD. SUITE 500

(Street)
METTAWA IL 60045

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BRUNSWICK CORP [ BC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
E.V.P. GEN COUNSEL & SECRETARY
3. Date of Earliest Transaction (Month/Day/Year)
02/16/2023
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/16/2023 A 9,610(1) A $88.45 48,545 D
Common Stock 02/16/2023 A 4,520(2) A $88.45 53,065 D
Common Stock 02/16/2023 F 4,257 D $88.45 48,808 D
Common Stock 02/16/2023 S 7,353(3) D $88.29(4) 41,455 D
Common Stock 3,161(5) I By Svgs Plan Trustee
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares were acquired pursuant to the officer's 2020 performance share grant that was released on February16,2023.
2. Restricted stock granted under the 2014 Stock Incentive Plan with right to have shares withheld to pay income taxes on lapse of restrictions.
3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.79 to $88.78.
5. Estimate of the number of shares held by the savings plan trustee as of February 17, 2023. This plan uses stock fund unit accounting and the number of shares that a participant is deemed to hold varies with the price of Brunswick Stock.
Remarks:
By: Power of Attorney For: /s/ Christopher Dekker 02/21/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.